ALB and coronary artery disorder: The C-reactive protein–albumin–lymphocyte (CALLY) indexis a novel inflammatory biomarker, and its association with the prognosis ofcoronary artery disease (CAD) after percutaneous coronary intervention (PCI) hasnot previously been studied.